Tykerb Tablet is formulated using lapatinib as main ingredient which is known to have highly efficient anti-cancerous activity against certain kinds of cancers. Being dual kinase inhibitor, it stops activity of HER2/neu & EGFR pathways. This tablet is most commonly utilized in combination therapy for HER-2 positive breast cancer. Tykerb Tablet is mainly metabolized by CYP3A4 enzyme in liver with superior protein binding abi9lity of more than 99%.
Features:
Has elimination half life of about 24 hours with repeated doses
Excreted in feces
Can also be used for metastatic breast cancer conditions
SURETY HEALTHCARE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |